TherapeuticsMD Inc. (TXMD)
0.87
-0.02 (-2.25%)
At close: Mar 24, 2025, 3:58 PM
0.87
0.86%
After-hours: Mar 24, 2025, 07:56 PM EDT
-2.25% (1D)
| Bid | 0.84 |
| Market Cap | 9.98M |
| Revenue (ttm) | 1.6M |
| Net Income (ttm) | -3.32M |
| EPS (ttm) | -0.35 |
| PE Ratio (ttm) | -2.47 |
| Forward PE | 3.06 |
| Analyst | n/a |
| Ask | 0.91 |
| Volume | 50,108 |
| Avg. Volume (20D) | 595,850 |
| Open | 0.89 |
| Previous Close | 0.89 |
| Day's Range | 0.83 - 0.90 |
| 52-Week Range | 0.70 - 2.44 |
| Beta | 1.18 |
About TXMD
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone...
Sector Healthcare
IPO Date May 9, 2007
Employees 1
Stock Exchange NASDAQ
Ticker Symbol TXMD
Website https://www.therapeuticsmd.com
